跳至主要内容
临床试验/NCT04717947
NCT04717947Unknown不适用

Interval Between Neoadjuvant Therapy and Surgery in the Treatment of Locally Advanced Rectal Cancer

Hospital Clinic of Barcelona1 个研究点 分布在 1 个国家目标入组 911 人开始时间: 2020年2月25日最近更新:
适应症

试验速览

阶段
不适用
入组人数
911
试验地点
1
主要终点
Distal resection margin (DRM)

研究概览

简要总结

The investigators evaluate the response of rectal cancer to neoadjuvant therapy and classify the response according to specific periods of time after the end of neoadjuvant treatment.

详细描述

In the treatment of locally advanced rectal cancer, an optimal interval between neoadjuvant therapy and surgery might improve oncological outcomes. Besides, those patients who achieve a good response might benefit from active surveillance, avoiding surgical comorbidities. This optimal interval is yet to be defined. This study will aim to better define the role of time interval between the end of neoadjuvant therapy (NAT) and TME in Spanish regions, together with analyzing the importance of restaging MRI and define the basis for implementing a "watch and wait" protocol.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Adult patients suitable for elective surgical resection of biopsy-confirmed rectal adenocarcinoma (0-15 cm from the anal verge) determined by rectal cancer protocol magnetic resonance imaging.
  • Patients treated with long-course neoadjuvant chemoradiotherapy (nCRT).
  • Patients treated with short-course radiotherapy with delayed surgery.
  • Clinical stage IIA, IIB, IIIA, IIIB, IIIC (cT3/cT4, or cN1/cN2 with any cT, M0) determined by rectal cancer protocol magnetic resonance imaging

排除标准

  • Intolerance or contraindication to planned NAT.
  • Patients who have not finished NAT for any reason.
  • Patients with unknown cT or cM.
  • Tumors previously treated with local excision or with distant metastatic disease.

结局指标

主要结局

Distal resection margin (DRM)

时间窗: 2000-2019

Described as free (DRM \>1 mm)

Quality of the specimen

时间窗: 2000-2019

Described as complete or incomplete

Pathological response

时间窗: 2000-2019

Grade as complete

Circumferential margin (CRM)

时间窗: 2000-2019

Described as free (CRM \>1 mm)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验